Work

Phase 1 Study Update of the Novel Pan-Pim Kinase Inhibitor LGH447 in Patients with Relapsed/ Refractory Multiple Myeloma

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.301.301

Authors: Marc S Raab, Enrique M Ocio, Sheeba K. Thomas, Andreas Günther, Yeow-Tee Goh, Daniel Lebovic, Andrzej Jakubowiak, Dongweon Song, F Xiang, Apurva Patel, K. Gary Vanasse, Shaji Kumar

Institutions: University Hospital Heidelberg, Instituto de Investigación Biomédica de Salamanca, The University of Texas MD Anderson Cancer Center, University Hospital Schleswig-Holstein, Singapore General Hospital, University of Michigan, University of Chicago, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4251288746

FWCI: 2.661

Cites:

Cited by: 31

Related to: 10